NOVAVAX INC (NASDAQ: NVAX)

Overview
current price
$7.09
$7.09
change
-0.36 | -4.77%
-0.36 | -4.77%
Yesterday's Close
7.44
open
7.56
volume
3.19 M
30d. avg volume.
4.41 M
1 day
7.08 - 7.60
52 weeks
5.01 - 11.55
p/e
3.70
beta
2.6849
market cap
1.21 B
dividend yield
0.00%
Industry
-
News and Commentary
Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales On Wednesday, Novavax Inc. (N...
RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: 'We're Prioritizing S... The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million, marking a major policy shift under Secretary Robert F. Kennedy Jr....
Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector Shares of Novavax Inc (NVAX
Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates Novavax, Inc. (NVAX&nb...
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.'s
Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful alliance of leading medical and public health organization...
Novavax's Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Pha... Novavax, Inc. (NVAX&nb...
Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children The U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced Tuesday that the COVID-19 vaccine will no longer be among the recommended vaccines for pregnant women...
Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety S... The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s
Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps Novavax, Inc. (NVAX&nb...
StockTwits
StockTwits

Join now and unlock premium features